Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RELAI: Field-based LA-CAB/RPV for PWH Out of Care
NCT07895823Phase 4Not yet recruiting
- Sponsor
- University of North Carolina at Chapel Hill
- Start
- Jan 2027
- Primary completion
- Sep 2028
- Countries
- 1
01
Overview
A Phase 4 trial of cabotegravir, rilpivirine in human immunodeficiency virus infection (HIV), sponsored by University of North Carolina at Chapel Hill. Planned start Jan 2027; status: not yet recruiting.
02
Drugs
cabotegravirrilpivirine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT07895823.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07895823.